Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Explore criteria to identify altcoins safe for long-term holding, including fundamentals, liquidity, and community support. Start evaluating with confidence.
27,729 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
The MORT ETF offers a double-digit yield, but its payout hinges on the health of its mortgage REIT holdings. This art...
Seagate Technology has rallied about 250% year-to-date as AI storage demand accelerates. This update weighs whether t...
BlackRock’s IBIT drew about $209 million in a single session, helping U.S. spot Bitcoin ETFs turn positive again. Mar...
The SEC has launched a public-comment process on novel ETFs, signaling tighter rules for crypto assets and leverage a...
Could Amazon hit a $4 trillion market value by 2027? This guide breaks down the odds, drivers, and actionable moves f...
As 2026 unfolds, a value-led rotation is drawing fresh money into the Vanguard Value ETF (VTV). With inflation coolin...
As war risk escalates in early 2026, builders brace for higher loan pricing and thinner demand. This report outlines ...
A short clip of a man in Brampton clearing snow with a lawnmower exploded into a national conversation about who belo...
Goldman Sachs now puts a one-year recession probability at about 25%. Here’s how that signal, plus energy volatility ...
Robinhood’s startup fund invests roughly $35 million across Stripe and ElevenLabs, signaling a strategic tilt toward ...
Iran tensions and hawkish policy signals are lifting yields, putting mortgage rates breaking higher and spring housin...